Summary of the safety profile: The most frequently reported adverse reactions were headache, nausea, and fatigue.
Tabulated summary of adverse reactions: The following adverse drug reactions have been identified with tenofovir alafenamide in patients with chronic hepatitis B (Table 1). The adverse reactions are listed as follows by body system organ class and frequency. Frequencies are defined as follows: very common, common, uncommon, rare or very rare. (See Table 1.)
Click on icon to see table/diagram/image